Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06812832 · ClinicalTrials.gov registry record · Phase 4
Simethicone as Part of ERAS in Bariatric Surgery Patients
A Phase 4 study of Post Operative Pain and Bariatric Surgery, sponsored by Madigan Army Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT06812832 is a Phase 4 study of Post Operative Pain and Bariatric Surgery that is actively recruiting participants, run by Madigan Army Medical Center. The registered enrollment target is 260 participants, above the 232-participant average among 56 other Post Operative Pain trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06812832, a Phase 4 study of Post Operative Pain and Bariatric Surgery, is actively recruiting participants, sponsored by Madigan Army Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery. The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Simethicone 80 MG
Study Locations (1)
Washington
- Madigan Army Medical Center - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2025-04-08 |
| Est. Completion | 2029-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06812832
The ClinicalTrials.gov registry entry for NCT06812832 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 232-participant average among 56 other Post Operative Pain trials with a reported enrollment target (12% higher). The listed sponsor is Madigan Army Medical Center, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Post Operative Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06812832 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06812832 about?
NCT06812832 is a clinical study titled "Simethicone as Part of ERAS in Bariatric Surgery Patients". By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gas...
What is the current status of trial NCT06812832?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 260 participants. The study started on 2025-04-08. Estimated completion is 2029-03.
What conditions does trial NCT06812832 study?
This clinical trial studies the following conditions: Post Operative Pain, Bariatric Surgery, Simethicone.
What interventions are being tested in trial NCT06812832?
The interventions under investigation include: Placebo (DRUG), Simethicone 80 MG (DRUG).
Who is sponsoring clinical trial NCT06812832?
This trial is sponsored by Madigan Army Medical Center, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06812832 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Operative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
RECRUITING · Phase 4
-
Preoperative Acetazolamide
RECRUITING · Phase 4
-
Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
RECRUITING · Phase 4
-
Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
RECRUITING · Phase 4
-
Post Operative Infusion Pump Pain Study
RECRUITING · Phase 4
-
ZYNRELEF for Pain Management in Total Knee Arthroplasty
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.